DANA SELLERS: Open Payments
NPI 1679071260 · SHARPSBURG, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$200 in 10 payments from 8 companies in 2025. Trend: 2023 $65 · 2024 $420 · 2025 $200
Food & beverage: $200
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 2 | $43 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Novo Nordisk Inc | 1 | $31 |
| PFIZER INC. | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
| ABBVIE INC. | 1 | $16 |
| Dynavax Technologies Corporation | 1 | $16 |
Products named: Dexcom G6 Transmitter, SHINGRIX, Ozempic, NURTEC ODT, GEMTESA, XIFAXAN, VRAYLAR, Heplisav-B.
Industry payments across GA — which companies pay providers there.
